Introduction The therapeutic armamentarium for the treatment of psoriasis, a chronic
inflammatory skin disease, is now reasonably broad and structured, with several therapeutic …

Psoriasis is a chronic, systemic, inflammatory disease that is often associated with serious
comorbid conditions such as cardiovascular disease, obesity, and diabetes. Many patients …

Background: In the management of moderate-to-severe psoriasis, increasingly complex
clinical scenarios necessitate practical tools for appropriate biologic therapy selection in …

Psoriasis is a chronic skin disease that results from the complex interaction between genetic
and environmental factors. Over the last few decades, scientific evidence has redirected the …

Psoriasis is a chronic autoimmune disease that affects approximately 2–3% of the world's
population. Although the cutaneous manifestations of the disease are the most prevalent …

Objectives A retrospective cohort study was carried out, which aimed to describe the
frequency and clinical features of adverse events in a cohort of patients with psoriasis and …

The advances in psoriasis management currently allow achieving a good control of the
disease. In particular, with the latest developed molecules, available evidence suggests that …

Over the past decade, biologics have become the gold standard in the treatment of
moderate-to-severe psoriasis for patients who have failed or who have contraindications to …

Biologic therapy is a well-established strategy for managing moderate and severe psoriasis.
Nevertheless, the high cost of such therapy, the relatively short span of clinical experience …

Psoriasis is a T-cell mediated skin disease that affects approximately 2% of the population
worldwide. Despite the prevalence of the disease and long-standing efforts to develop …